Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 17.5.1. Oral rehydration |
Outras observações: glucose: 75 mEq; sodium: 75 mEq or mmol/L; chloride: 65 mEq or mmol/L; potassium: 20 mEq or mmol/L; citrate: 10 mmol/L ; osmolarity: 245 mOsm/L; glucose: 13.5 g/L; sodium chloride: 2.6 g/L; potassium chloride: 1.5 g/L; trisodium citrate dihydrate+: 2.9 g/L + trisodium citrate dihydrate may be replaced by sodium hydrogen carbonate (sodium bicarbonate) 2.5 g/L. However, as the stability of this latter formulation is very poor under tropical conditions, it is only recommended when manufactured for immediate use. |
WHO Model List of Essential Medicines (2021) | 26.1 Oral |
Outras observações: See section 17.5.1. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 17.5.1. Oral rehydration |
Outras observações: glucose: 75 mEq; sodium: 75 mEq or mmol/L; chloride: 65 mEq or mmol/L; potassium: 20 mEq or mmol/L; citrate: 10 mmol/L ; osmolarity: 245 mOsm/L; glucose: 13.5 g/L; sodium chloride: 2.6 g/L; potassium chloride: 1.5 g/L; trisodium citrate dihydrate+: 2.9 g/L + trisodium citrate dihydrate may be replaced by sodium hydrogen carbonate (sodium bicarbonate) 2.5 g/L. However, as the stability of this latter formulation is very poor under tropical conditions, it is only recommended when manufactured for immediate use. |
WHO Model List of Essential Medicines (2021) | 26.1 Oral |
Outras observações: See section 17.5.1. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 17.5.1. Oral rehydration |
Outras observações: glucose: 75 mEq; sodium: 75 mEq or mmol/L; chloride: 65 mEq or mmol/L; potassium: 20 mEq or mmol/L; citrate: 10 mmol/L ; osmolarity: 245 mOsm/L; glucose: 13.5 g/L; sodium chloride: 2.6 g/L; potassium chloride: 1.5 g/L; trisodium citrate dihydrate+: 2.9 g/L + trisodium citrate dihydrate may be replaced by sodium hydrogen carbonate (sodium bicarbonate) 2.5 g/L. However, as the stability of this latter formulation is very poor under tropical conditions, it is only recommended when manufactured for immediate use. |
WHO Model List of Essential Medicines (2021) | 26.1 Oral |
Outras observações: See section 17.5.1. |
Listas | Seção | Observação |
---|---|---|
Chile | Essential and Prioritized Medications | Sem observações |
Listas | Seção | Observação |
---|---|---|
Chile | Essential and Prioritized Medications | Sem observações |